Mobile
  • Search
  • Advanced search
  • Multi-criteria search
  • Who are we ?
  • Log in
  • Sign up
  • Français
  • English

Kusajili – Clinical trials directory

Your research

Clear all filters

Filtres
organs
Specialty
Type
Promoter
  • nct (2)
Country
  • Argentina (2)
  • Australia (2)
  • Belgium (2)
  • Canada (2)
  • France (2)
  • Korea, Republic of (2)
  • Poland (2)
  • United Kingdom (2)
  • United States (2)
  • Colombia (1)
  • Egypt (1)
  • Finland (1)
  • Germany (1)
  • Guatemala (1)
  • Hungary (1)
  • Iceland (1)
  • India (1)
  • Italy (1)
  • Malaysia (1)
  • Mexico (1)
  • Philippines (1)
  • Romania (1)
  • Russian Federation (1)
  • Singapore (1)
  • Spain (1)
  • Sweden (1)
  • Taiwan, Province of China (1)
Source
  • nct (2)
Phase
  • complete (2)

Country: Korea, Republic of,United Kingdom,Poland,United States,Australia,Argentina
nct Update Il y a 5 ans

Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis This study will assess the safety and efficacy of secukinumab compared to placebo and etanercept in patients that have moderate to severe, chronic, plaque-type psoriasis.

  • Country Argentina, Australia, Belgium, Canada, Colombia, Egypt, Finland, France, Germany, Guatemala, Hungary, Iceland, India, Italy, Korea, Republic of, Philippines, Poland, Romania, Singapore, Spain, Sweden, United Kingdom, United States,
  • organs None
  • Specialty None
Closed trial
More information
nct Update Il y a 5 ans

Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction The purpose of this study is to evaluate the efficacy and safety of dapoxetine compared to placebo in men with premature ejaculation and erectile dysfunction who are currently being treated with a phosphodiesterase-5 inhibitor (ie, sildenafil, vardenafil, or tadalafil) for erectile dysfunction.

  • Country Argentina, Australia, Belgium, Canada, France, Korea, Republic of, Malaysia, Mexico, Poland, Russian Federation, Taiwan, Province of China, United Kingdom, United States,
  • organs None
  • Specialty None
Closed trial
More information

  • 1

Who are we ?

Kusajili was created to respond to a request from physicians to simplify access to patient registries and inclusion. Kusajili is regularly updated according to new French and international trials. [email protected]

Kusajili and MyHomeDoctor

MyHomeDoctor software unique to the world, created with surgeons, for follow-up and analysis of patient follow-up. Kusajili and MyHomeDoctor partners, help clinical research through improved patient follow-up and automatic inclusion.

Sign up

Sign up
Français - English - CGU - Cookies

©2024 Kusajili France - Kusajili International - MedSynApps - MyHomeDoctor.